United States · FDA National Drug Code directory
REZLIDHIA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71332-005_6df73356-e3c1-498d-af08-c34b5d257bdb
- Product NDC
- 71332-005
- Form
- CAPSULE
- Composition / generic term
- olutasidenib
- Labeler
- Rigel Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20221201
- Source listing expiry
- 20261231
Source-listed ingredients
- OLUTASIDENIB — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (71332-005-01) · 71332-005-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →